Loading...
Therapeutic doses of hydroxyurea cause telomere dysfunction and reduce TRF2 binding to telomeres
Hydroxyurea (HU) is a chemotherapeutic agent commonly used for various malignancies and hematological disorders, including chronic myelogenous leukemia and sickle cell anemia. We show here that chronic, low-level treatment with HU induces a variety of defects in telomere replication and maintenance....
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3313557/ https://ncbi.nlm.nih.gov/pubmed/19363303 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|